UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group

Annals of oncology, 2020-11, Vol.31 (11), p.1491-1505

2020

Volltextzugriff (PDF)

Prevalence and mutational determinants of high tumor mutation burden in breast cancer

Annals of oncology, 2020-03, Vol.31 (3), p.387-394

2020

Volltextzugriff (PDF)

Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer

Annals of oncology, 2020-05, Vol.31 (5), p.590-598

2020

Volltextzugriff (PDF)

Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia

Leukemia, 2013-04, Vol.27 (4), p.968-971

2013

Volltextzugriff (PDF)

Abstract CS1-1: The genomics of metastatic breast cancer: What are we learning?

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.CS1-1-CS1-1

Wagle, N

2017

Volltextzugriff (PDF)

ESTIMATING AND MAPPING CHLOROPHYLL-A CONCENTRATION OF PHEWA LAKE OF KASKI DISTRICT USING LANDSAT IMAGERY

ISPRS annals of the photogrammetry, remote sensing and spatial information sciences, 2019-12, Vol.IV-5/W2, p.127-132

2019

Volltextzugriff (PDF)

Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma

Neuro-oncology (Charlottesville, Va.), 2012-03, Vol.14 (3), p.333-343

2012

Volltextzugriff (PDF)

428 Clinical acquired resistance to combined RAF/EGFR or RAF/MEK inhibition in BRAF mutant colorectal cancer (CRC) patients through MAPK pathway alterations

European journal of cancer (1990), 2014-11, Vol.50, p.141-141

2014

Volltextzugriff (PDF)

Successful whole-exome sequencing from a prostate cancer bone metastasis biopsy

Prostate cancer and prostatic diseases, 2014-03, Vol.17 (1), p.23-27

2014

Volltextzugriff (PDF)

Artificial Intelligence-Based Ocular Motor Biomarkers for Myasthenia Gravis Diagnosis (P10-11.016)

Neurology, 2024-08, Vol.103 (3), p.e209639

2024

Volltextzugriff (PDF)

Somatic ERCC2 Mutations Confer Cisplatin Sensitivity in Muscle-Invasive Urothelial Cancer

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S88-S88

2014

Volltextzugriff (PDF)

Genomic Predictors of Leptomeningeal Disease Development among Patients with Brain Metastases

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.S76-S76

2023

Volltextzugriff (PDF)

A Genomic Score to Predict Local Control among Patients with Brain Metastases Managed with Radiation

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e122-e123

2023

Volltextzugriff (PDF)

1026P Updated results from the phase I 1456-0001 study for intratumoral (IT) VSV-GP (BI 1831169) in patients with advanced solid tumors

Annals of oncology, 2024-09, Vol.35, p.S693-S693

2024

Volltextzugriff (PDF)

Abstract PD4-01: The role of FGF/FGFR axis in resistance to SERDs and CDK4/6 inhibitors in ER+ breast cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.PD4-01-PD4-01

2018

Volltextzugriff (PDF)

Abstract P3-03-08: A large-scale functional screen to identify resistance mechanisms to selective estrogen receptor degraders fulvestrant and GDC-810 in ER+ breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P3-P3-03-08

2017

Volltextzugriff (PDF)

Abstract P3-04-08: The role of HER2 mutations in resistance to endocrine therapy in ER+ breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P3-P3-04-08

2017

Volltextzugriff (PDF)

Abstract P5-17-01: Patient-derived organoid models of inflammatory breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P5-P5-17-01

2019

Volltextzugriff (PDF)

137P First-in-human results from a phase I dose-escalation study of VSV-GP (BI 1831169) in patients with advanced solid tumors

Immuno-oncology technology, 2023-12, Vol.20, p.100609, Article 100609

2023

Volltextzugriff (PDF)

Human Wild-Type Tau Interacts with wingless Pathway Components and Produces Neurofibrillary Pathology in Drosophila

Neuron (Cambridge, Mass.), 2002-05, Vol.34 (4), p.509-519

2002

Volltextzugriff (PDF)

A p53-Dependent Checkpoint Pathway Prevents Rereplication

Molecular cell, 2003-04, Vol.11 (4), p.997-1008

2003

Volltextzugriff (PDF)

Abstract PD9-03: The genomic landscape of de novo metastatic breast cancer (MBC)

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.PD9-03-PD9-03

2019

Volltextzugriff (PDF)

Abstract P2-01-04: The whole transcriptional landscape of circulating tumor cells compared to metastases in stage IV breast cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P2-P2-01-04

2018

Volltextzugriff (PDF)

Long-term outcome of cyclocryotherapy for refractory pediatric glaucoma

Ophthalmology (Rochester, Minn.), 1998-10, Vol.105 (10), p.1921-1927

1998

Volltextzugriff (PDF)

1 – 25 von 335

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(286)
Mit Volltextzugriff
(278)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group

Prevalence and mutational determinants of high tumor mutation burden in breast cancer

Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer

Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia

Abstract CS1-1: The genomics of metastatic breast cancer: What are we learning?

ESTIMATING AND MAPPING CHLOROPHYLL-A CONCENTRATION OF PHEWA LAKE OF KASKI DISTRICT USING LANDSAT IMAGERY

Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma

428 Clinical acquired resistance to combined RAF/EGFR or RAF/MEK inhibition in BRAF mutant colorectal cancer (CRC) patients through MAPK pathway alterations

Successful whole-exome sequencing from a prostate cancer bone metastasis biopsy

Artificial Intelligence-Based Ocular Motor Biomarkers for Myasthenia Gravis Diagnosis (P10-11.016)

Somatic ERCC2 Mutations Confer Cisplatin Sensitivity in Muscle-Invasive Urothelial Cancer

Genomic Predictors of Leptomeningeal Disease Development among Patients with Brain Metastases

A Genomic Score to Predict Local Control among Patients with Brain Metastases Managed with Radiation

1026P Updated results from the phase I 1456-0001 study for intratumoral (IT) VSV-GP (BI 1831169) in patients with advanced solid tumors

Abstract PD4-01: The role of FGF/FGFR axis in resistance to SERDs and CDK4/6 inhibitors in ER+ breast cancer

Genomic profiling of ER + breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance

Abstract P3-03-08: A large-scale functional screen to identify resistance mechanisms to selective estrogen receptor degraders fulvestrant and GDC-810 in ER+ breast cancer

Abstract P3-04-08: The role of HER2 mutations in resistance to endocrine therapy in ER+ breast cancer

Abstract P5-17-01: Patient-derived organoid models of inflammatory breast cancer

137P First-in-human results from a phase I dose-escalation study of VSV-GP (BI 1831169) in patients with advanced solid tumors

Human Wild-Type Tau Interacts with wingless Pathway Components and Produces Neurofibrillary Pathology in Drosophila

A p53-Dependent Checkpoint Pathway Prevents Rereplication

Abstract PD9-03: The genomic landscape of de novo metastatic breast cancer (MBC)

Abstract P2-01-04: The whole transcriptional landscape of circulating tumor cells compared to metastases in stage IV breast cancer

Long-term outcome of cyclocryotherapy for refractory pediatric glaucoma

Suchergebnisse filtern